Cholelithiasis in premature infants treated with parenteral nutrition and furosemide

Refractory hypoxemia associated with neonatal pulmonary disease: The use and limitations of tolazoline, J PEmAXR 95:595, 1979.

Abstract

1. Korones SF, and Fabien GA: Successful treatment of fetal circulation, Pediatr Res 9:367, 1975. 2. Goetzman BW, Sunshine P, Johnson JD, Wennberg RP, Hackel A, Merten DF, Bartoletti AL, and Silverman NH: Neonatal hypoxia and pulmonary vasospasm: Response to tolazoline, J PEmATR 89:617, 1976. 3. Levin DL, Heymann MA, Kitterman JA, Gregory GA, Phibbs RH, and Rudolph AM: Persistent pulmonary hypertension of the newborn infant, J PEI~IAXr~ 89:626, 1976. 4. Purohit DM, Pal S, and Levkoff AH: Effect of tolazoline on persistent hypoxemia in neonatal respiratory distress, Crit Care Med 6:14, 1978. 5. Mclntosh N, and Waiters RO: Effect of tolazoline in severe HMD, Arch Dis Child 54:105, 1978. 6. Rudolph AM, Paul MH, Somrner LS, and Nadas AS: Effects of tolazoline hydrochloride on circulatory dynamics of patients with pulmonary hypertension, Am Heart J 55:424, 1958. 7. Grover RF, Reeves JT, and Blount SG: Tolazoline hydrochloride: An effective pulmonary vasodilator, Am Heart J 61:5, 1961. 8. Drummond WH, Peckham GJ, and Fox WW: The clinical profile of the newborn with persistent pulmonary hypertension, Clin Pediatr 16:335, 1977. 9. Fox WW, Gewitz MH, Dinwiddie R, Drummond WH, and Peckham GJ: Pulmonary hypertension in the perinatal aspiration syndromes, Pediatrics 59:205, 1977. 10. Stevenson DK, Kasting DS, Darnall RA, Ariagno RL, Johnson JD, Malachowski N, Beets CL, and Sunshine P: Refractory hypoxemia associated with neonatal pulmonary disease: The use and limitations of tolazoline, J PEmAXR 95:595, 1979. 11. Peckham GJ, and Fox WW: Physiologic factors affecting pulmonary artery pressure in infants with persistent pulmonary hypertension, J PEDIATR 93:1005, 1978.